Mae gwerthwchigymru.llyw.cymru yn defnyddio cwcis sy'n hanfodol er mwyn i'r safle weithio. Rydym hefyd yn defnyddio cwcis nad ydynt yn hanfodol i'n helpu i wella gwasanaethau digidol y Llywodraeth. Mae unrhyw ddata a gesglir yn ddienw. Drwy barhau i ddefnyddio'r safle hwn, rydych yn cytuno i'n defnydd o gwcis

Derbyn ein defnydd o gwcis Gosodiadau cwcis

Gweld Hysbysiad

Nid yw'r prynwr yn defnyddio'r wefan hon i weinyddu'r hysbysiad. I gofnodi eich diddordeb neu gael gwybodaeth neu ddogfennau ychwanegol, darllenwch y cyfarwyddiadau yn Nhestun Llawn yr Hysbysiad. (NODER: Nid oes angen ymateb i Hysbysiadau Dyfarnu Contractau a Hysbysiadau Gwybodaeth Ymlaen Llaw fel arfer)

Ychwanegu hysbysiad at fy Rhestr Diddordeb

Manylion yr Hysbysiad

Teitl: Managed Service for the Bacterial Screening of Platelets
OCID: ocds-h6vhtk-03590d
ID yr Awdurdod: AA72163
Cyhoeddwyd gan: NHS Blood and Transplant
Dyddiad Cyhoeddi: 05/08/22
Dyddiad Cau:
Amser Cau:
Math o Hysbysiad: Hysbysiad Gwybodaeth Ymlaen Llaw (PIN)
Yn Cynnwys Dogfennau: Na
Yn SPD: Na
Crynodeb:

NHSBT requires a direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which must include all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT’s existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, instruments, consumables, and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT’s host IT system (PULSE) without the need for changes to PULSE. <br/><br/>NHSBT are looking for a fully integrated, high throughput, automated bacterial screening system which can detect bacterial contamination in platelet components. The system will be used in Filton (Bristol), Manchester and Colindale (London) where approximately 270,000 adult therapeutic doses of platelets are manufactured each year. NHSBT are seeking to engage with suppliers who can provide this. The system must be CE/UKCA marked. Additional requirements to be included with the managed service contract include:<br/>- continuous calibrated temperature monitoring<br/>- ability to integrate with NHSBT information management system<br/>- alerting software (for positive results, hardware errors, temperature excursions)<br/>- consumables (including, but not limited to, sterile sampling connecting devices)<br/><br/>All test protocols must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and the Good Practice Guidelines for Blood Establishments that are Required to Comply with Directive 2005/62/EC. These are published in the 20th edition of the Guide to the preparation, use and quality assurance of blood components. <br/><br/><br/>It is NHSBTs’ intention to engage with the market to gather detailed information about the market capabilities. The format for this will be communicated to those that respond to this PIN. Virtual Supplier Engagement days are likely to be a Webinar followed by individual supplier presentation days. Expressions of interest should be e-mailed to jo.murphy@nhsbt.nhs.uk by no later than 12:00 hours on 25th August 2022.

Hysbysiad gwybodaeth ymlaen llaw

Hysbysiad gwybodaeth ymlaen llaw yn unig yw hwn

Cyfarwyddeb 2014/24/EU - Cyfarwyddeb y Sector Cyhoeddus

Cyfarwyddeb 2014/24/EU

Adran I: Endid contractio

I.1) Enw a chyfeiriad

NHS Blood and Transplant

NHS Blood and Transplant

500 North Bristol Park

Bristol

BS34 7QH

UK

Person cyswllt: Jo Murphy

Ffôn: +44 1179212718

E-bost: jo.murphy@nhsbt.nhs.uk

NUTS: UKK11

Cyfeiriad(au) rhyngrwyd

Prif gyfeiriad: https://www.nhsbt.nhs.uk/

Cyfeiriad proffil y prynwr: https://www.nhsbt.nhs.uk/

I.3) Cyfathrebu

Gellir cael gwybodaeth ychwanegol o'r cyfeiriad uchod


Mae cyfathrebu electronig yn gofyn am ddefnyddio offer a dyfeisiau nad ydynt ar gael yn gyffredinol. Mae mynediad uniongyrchol anghyfgyfyngiedig a llawn i'r offer a dyfeisiau hyn yn bosibl, yn rhad ac am ddim, yn:

https://health-family.force.com/s/Welcome


I.4) Y math o awdurdod contractio

Corff a lywodraethir gan gyfraith gyhoeddus

I.5) Prif weithgaredd

Iechyd

Adran II: Gwrthrych

II.1) Cwmpas y caffaeliad

II.1.1) Teitl

Managed Service for the Bacterial Screening of Platelets

II.1.2) Prif god CPV

85111810

 

II.1.3) Y math o gontract

Gwasanaethau

II.1.4) Disgrifiad byr

This Prior Information Notice (PIN) follows 2021/S 000-013561 released on the 16th June 2021 and all information herein supersedes that of 2021/S 000-013561.<br/><br/>This Prior Information Notice (PIN) is separate to any tender opportunity and not related in any form whatsoever to any subsequent activity that NHSBT may wish to pursue. The purpose of this PIN is to consult the market to improve NHSBT’s knowledge on the status of manufacturer(s) or economic operator(s) that can supply a commercially available automated, high-throughput automated bacterial screening system which can detect bacterial contamination in platelet components. <br/>NHSBT needs to gauge market interest in a new provision of this service. It is the intention of NHSBT to further consult and engage with only those manufacturer(s) and economic operator(s) who meet the outline requirements.

II.1.5) Cyfanswm gwerth amcangyfrifedig

Gwerth heb gynnwys TAW: 31 200 000.00 GBP

II.1.6) Gwybodaeth am lotiau

Mae’r contract hwn wedi’i rannu’n lotiau: Na

II.2) Disgrifiad

II.2.2) Cod(au) CPV ychwanegol

33696200

38434520

48921000

71632000

85111810

71600000

85146000

71900000

33698100

II.2.3) Man cyflawni

Cod NUTS:

UK

II.2.4) Disgrifiad o’r caffaeliad

NHSBT requires a direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which must include all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT’s existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, instruments, consumables, and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT’s host IT system (PULSE) without the need for changes to PULSE. <br/><br/>NHSBT are looking for a fully integrated, high throughput, automated bacterial screening system which can detect bacterial contamination in platelet components. The system will be used in Filton (Bristol), Manchester and Colindale (London) where approximately 270,000 adult therapeutic doses of platelets are manufactured each year. NHSBT are seeking to engage with suppliers who can provide this. The system must be CE/UKCA marked. Additional requirements to be included with the managed service contract include:<br/>- continuous calibrated temperature monitoring<br/>- ability to integrate with NHSBT information management system<br/>- alerting software (for positive results, hardware errors, temperature excursions)<br/>- consumables (including, but not limited to, sterile sampling connecting devices)<br/><br/>All test protocols must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and the Good Practice Guidelines for Blood Establishments that are Required to Comply with Directive 2005/62/EC. These are published in the 20th edition of the Guide to the preparation, use and quality assurance of blood components. <br/><br/><br/>It is NHSBTs’ intention to engage with the market to gather detailed information about the market capabilities. The format for this will be communicated to those that respond to this PIN. Virtual Supplier Engagement days are likely to be a Webinar followed by individual supplier presentation days. Expressions of interest should be e-mailed to jo.murphy@nhsbt.nhs.uk by no later than 12:00 hours on 25th August 2022.

II.3) Dyddiad amcangyfrifedig ar gyfer cyhoeddi’r hysbysiad contract:

01/11/2022

Section IV: Gweithdrefn

IV.1) Disgrifiad

IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)

The procurement is covered by the Government Procurement Agreement: Ydy

Section VI: Gwybodaeth ategol

VI.5) Dyddiad anfon yr hysbysiad hwn

04/08/2022


Gwybodaeth a ychwanegwyd at yr hysbysiad ers iddo gael ei gyhoeddi.

Gwybodaeth ychwanegol a ychwanegwyd at yr hysbysiad ers ei gyhoeddi.
Nid oes unrhyw wybodaeth bellach wedi'i lanlwytho.
Prif Gyswllt: jo.murphy@nhsbt.nhs.uk
Cyswllt Gweinyddol: Dd/g
Cyswllt Technegol: Dd/g
Cyswllt Arall: Dd/g

Categorïau Nwyddau

Categorïau Nwyddau
Rhif AdnabodTeitlPrif Gategori
48921000Automation systemOffice automation software package
38434520Blood analysersAnalysers
85111810Blood analysis servicesHospital services
33696200Blood-testing reagentsReagents and contrast media
71900000Laboratory servicesArchitectural, construction, engineering and inspection services
33698100Microbiological culturesClinical products
85146000Services provided by blood banksMiscellaneous health services
71632000Technical testing servicesTechnical inspection and testing services
71600000Technical testing, analysis and consultancy servicesArchitectural, construction, engineering and inspection services

Lleoliadau Dosbarthu

Lleoliad Delifriad
Rhif AdnabodDisgrifiad
100DU - Holl

Cyfyngiadau Rhanbarthol ar y Rhybuddion

Mae’r prynwr wedi cyfyngu’r rhybuddion ar gyfer yr hysbysiad hwn i gyflenwyr yn y rhanbarthau canlynol.

Cyfyngiadau Rhanbarth Rhybudd
Nid oes cyfyngiadau ar y rhybuddion ar gyfer yr hysbysiad hwn.

Copyright © GwerthwchiGymru